Valuation: Proto Script Pharmaceutical Corp.

Market Cap 1.97M 1.72M 1.59M 1.47M 2.79M 187M 2.83M 19.01M 7.39M 92.07M 7.38M 7.22M 318M P/E 2015 *
-
P/E 2016 -41.4x
Enterprise Value 2.01M 1.76M 1.62M 1.51M 2.86M 191M 2.9M 19.47M 7.57M 94.31M 7.56M 7.4M 326M EV / Sales 2015 *
-
EV / Sales 2016 394x
Free-Float
89.82%
Yield 2015 *
-
Yield 2016 -
3 months+100.00%
6 months+100.00%
Current year+100.00%
1 month 0
Extreme 0.0002
0
Current year 0
Extreme 0.0001
0
1 year 0
Extreme 0.0001
0
3 years 0
Extreme 0
0
5 years 0
Extreme 0
0.02
10 years 0
Extreme 0
2.2
Manager TitleAgeSince
Chief Executive Officer 58 2016-06-28
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--%-33.33%-.--% 11.38K
+0.14%+4.51%-15.42%+48.80% 72.75B
-2.30%-1.86%+5.98%+85.55% 21.11B
-1.38%+3.22%-3.27%+5.23% 15.38B
-0.73%+1.20%-3.57%+15.67% 13.81B
+0.04%+0.09%+19.99%+44.85% 11.93B
-2.94%-1.62%+28.47%+111.58% 8.15B
-0.69%+5.60%+55.36%+110.96% 6.93B
-0.06%-5.80%+26.04%+121.96% 5.64B
-0.46%+2.71%+1.74%-0.46% 5.22B
Average -0.82%+0.42%+8.20%+54.41% 16.09B
Weighted average by Cap. -0.62%+3.18%-0.53%+53.14%

Financials

2015 2016
Net sales 881K 771K 711K 659K 1.25M 83.66M 1.27M 8.52M 3.31M 41.29M 3.31M 3.24M 143M 789K 690K 636K 590K 1.12M 74.88M 1.14M 7.63M 2.97M 36.95M 2.96M 2.9M 128M
Net income -145K -127K -117K -109K -206K -13.79M -209K -1.4M -546K -6.8M -545K -533K -23.52M -7.18M -6.29M -5.79M -5.37M -10.19M -682M -10.36M -69.46M -27.01M -336M -26.97M -26.38M -1.16B
Net Debt 27.07K 23.69K 21.83K 20.23K 38.41K 2.57M 39.03K 262K 102K 1.27M 102K 99.42K 4.38M 47.78K 41.81K 38.54K 35.72K 67.81K 4.54M 68.9K 462K 180K 2.24M 179K 176K 7.74M
Logo Proto Script Pharmaceutical Corp.
Proto-Script Pharmaceuticals, Corp., formerly Yanex Group, Inc. is a development-stage company. The Company is primarily in the business of repair power wheelchairs and scooters, which are classified as durable medical equipment (DME) products and reimbursable by healthcare insurance providers. The Company has various contracts with state and governmental insurance providers, among others. These contracts provide the Company the right to sell and repair DME. The Company's health care insurance contracts allow it the ability to service patients nationally. The Company intends to expand its market through additional contracts and open several repair facilities throughout the continental United States. The Company currently has repair facilities in Las Vegas, Nevada, Rancho-Cucamonga, and Anaheim, California. As of June 30, 2016, the Company had not generated any revenues.
Employees
13
  1. Stock Market
  2. Stocks
  3. PSCR Stock